The InfinityLab Pro iQ Series mass detectors were launched by Agilent Technologies in India. The series is designed for next-generation liquid chromatography-mass detection (LC-MS) and aims to improve how impurities, trace contaminants, and complex
Apollo Home Healthcare in collaboration with the Apollo Indraprastha Hospitals has launched a integrated palliative care at home service in New Delhi. This is a ground breaking step towards meeting the increasing demands for compassionate...
Pharma company Corona Remedies is set to further bolster its presence in cardiology and hormones for women with seven major brands purchased from Bayer's Indian pharmaceuticals division. The acquisition would take effect on July 16, 2025, and is...
TrioTree Technologies, a leading healthcare IT solutions provider, has reached a major technological breakthrough with the successful deployment of its AI and NLP-powered voice-to-structured-data system across partner clinics. This cutting-edge...
India's pharmaceutical and healthcare industry saw 57 deals worth $1.3 billion in IPO and Qualified Institutional Placement (QIP) deal activity in the quarter ending June 2025, based on a report by Grant Thornton Bharat.
In a landmark deal that will transform diabetes care in India, Emcure Pharmaceuticals has entered an exclusive partnership with Sanofi India to sell and distribute some of Sanofi's most established oral anti-diabetic (OAD) products in the country...
AstraZeneca Pharma India has obtained an approval by the Central Drugs Standard Control Organisation (CDSCO) to import and market Durvalumab solution for infusion with an expanded indication in India.
India and Uzbekistan are set to increase cooperation in the pharmaceutical and medical industries after a virtual high-level discussion involving stakeholders of both countries. The session had stakeholders from Pharmexcil
An appeal has been made to the Prime Minister by Sumanata Kumar Tiwari, the joint director-cum-drug controller of Jharkhand, for a significant overhaul of the current regulatory framework to combat the escalating menace of counterfeit medicines
The US Food and Drug Administration (FDA) has granted new approval for Bayer’s finerenone (Kerendia) with a new indication to treat adults with heart failure and a left ventricular ejection fraction (LVEF) of 40% or higher...